Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-003645
Filing Date
2015-05-08
Accepted
2015-05-08 06:06:57
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nvet-10q_20150331.htm 10-Q 1904889
2 EX-31.1 nvet-ex311_201503317.htm EX-31.1 9636
3 EX-31.2 nvet-ex312_201503316.htm EX-31.2 9557
4 EX-32.1 nvet-ex321_201503319.htm EX-32.1 6957
5 EX-32.2 nvet-ex322_201503318.htm EX-32.2 7159
  Complete submission text file 0001564590-15-003645.txt   9056500

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nvet-20150331.xml EX-101.INS 1391939
7 XBRL TAXONOMY EXTENSION SCHEMA nvet-20150331.xsd EX-101.SCH 55986
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvet-20150331_cal.xml EX-101.CAL 33889
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvet-20150331_def.xml EX-101.DEF 176264
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvet-20150331_lab.xml EX-101.LAB 383379
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvet-20150331_pre.xml EX-101.PRE 313586
Mailing Address NATL INST FOR BIOPROCESSING RESEARCH FOSTERS AVENUE, MOUNT MERRION BLACKROCK CO. DUBLIN L2 00000
Business Address NATL INST FOR BIOPROCESSING RESEARCH FOSTERS AVENUE, MOUNT MERRION BLACKROCK CO. DUBLIN L2 00000 353 1 215 8100
Nexvet Biopharma plc (Filer) CIK: 0001618561 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36828 | Film No.: 15844335
SIC: 2834 Pharmaceutical Preparations